Table 19. Rationality behind the used formulation in COVID-19 during 28 days-60 days (Punaravartaka Jwara phase) in Add-on Ayurveda Group (Group 1) – Ayurvedic Medicine Track.
*n represents the count of patients who received the specified medication within the given timeframe
+Dosage and frequency were decided based on the Ayurveda physician’s clinical judgement
| Medicine Name | Rationale | Dosage+ | n (%)* | Frequency of intake+ |
| Kashyam | ||||
| Bharangyadi Kashayam | Sannipataja jwara(complicated fevers involving all three doshas), vishamajwara(intermittent fever), jeerna jwara(chronic fever), shirograha(headache), parshwashoola (pain in the flanks of the chest), hrith shola(chest pain around the heart), kasa(cough), shwasa(dyspnea) , tandra(semi-comatose condition) and agnimandhya(low metabolism). | 7.5 - 15 ml | 19 (90.5%) | Once/Twice |
| Indukantham Kashayam | Vata predominant type of fever associated with cough, breathing difficulty and fluid accumulation. | 7.5 - 15 ml | 15 (71.4%) | Once/Twice |
| Nayopayam Kashayam | Given during acute phase of COVID-19 with acute dyspnea, bloatedness, reverse peristalsis, belching associated with chest discomfort. | 7.5 ml | 8 (38.1%) | Once/Twice |
| Drakshadi Kashyam | In Chronic fever and Vomiting | 7.5 - 15 ml | 6 (28.6%) | Once/Twice |
| Panchathikthakam Kashayam | All eight type of fever as classified in Ayurveda associated with Kasa swasa. | 7.5 ml | 3 (14.3%) | Once/Twice |
| Guduchyadi Kashayam | In fever, vomiting, renal disorders, migraine, and diabetes. | 7.5 ml | 2 (9.5%) | Once/Twice |
| Rasonadi kashayam | Given in both acute and chronic COVID-19 cases where cardiovascular stress, and coagulopathy symptoms are high. | 7.5 ml | 2 (9.5%) | Twice |
| Patolakadurohinyadi Kashayam | In Kapha Pitta type of fever associated with Vomiting, Loss of appetite, skin rashes and symptoms of toxicity. | 7.5 ml | 1 (4.8%) | Twice |
| Gulika/Pills | ||||
| Suvarnamukatadi | Fever, vertigo, fatigue, loss of smell, and semi-comatose conditions. | 27 - 54 mg | 14 (66.7%) | Once/Twice/four |
| Gorochanadi Gulika | Fever associated with giddiness, nausea, breathlessness, General weakness, headache, Asthma, hiccups, cough, Hemiplegia and Ansomia. | 100 mg | 12 (57.1%) | Once/Twice/four |
| Swasanandam | Acute dyspnea. | 50mg | 3 (14.3%) | Once/Twice |
| Bhasmam | ||||
| Pravala Bhasmam | Acute dyspnea associated with hyperacidity and to iniate innate immune response. | 125 - 250 mg | 12 (57.1%) | Every 3 hours/Twice/once |
| Lehyam | ||||
| Agasthyarasayanam | Given both in acute and chronic condition of Cough, Dyspnoea, Rhinitis, Hiccup, Fever, Lack of appetite in COVID patients. | 5 - 6 g | 12 (57.1%) | Every 3 hours/Twice/once |
| Vidaryadi Lehyam | Given during both acute and chronic COVID-19 patients showing symptoms of fatigue, weight loss, myalgia, shortness of breath having moderate or good digestive activity. | 5 - 6 g | 6 (28.6%) | Every 3 hours/Twice |
| Brahmarasayana | Given both in acute and chronic condition of Cough, Dyspnoea, Rhinitis, Hiccup, Fever, Lack of appetite in COVID patients. | 5 - 6 g | 4 (19%) | Every 3 hours/Twice/once |
| Gritham | ||||
| Baladi Gritham | Given during both acute and chronic COVID-19 patients showing symptoms of fatigue, shortness of breath, persistent reoccurring fever, and lung consolidation. | 1/2 - 5 - 6 g | 18 (85.7%) | Once/Twice |